Alia S. Dadabhai, MD

Tsion Abdi, M.D., is a gastroenterologist specializing in scleroderma bowel disease and gastrointestinal motility issues in patients with scleroderma. She also treats patients with heartburn-related conditions and performs colon cancer screenings. Dr. Abdi is an assistant professor of medicine in the gastroenterology and hepatology division.She earned her M.D. from the Georgetown University School of Medicine. She completed her residency at MedStar Georgetown University Medical Center and performed a fellowship in gastroenterology at Yale-New Haven Hospital. Dr. Abdi joined the Johns Hopkins faculty in 2016.Dr. Abdi has received several awards, including the Wesley Oler, M.D., Award for an Outstanding Resident Physician. She is a member of the American Gastroenterological Association, the American College of Gastroenterology and the American Medical Association.

Gastroenterologist Florin Selaru has faculty appointments to the Division of Gastroenterology and Hepatology; the Johns Hopkins Kimmel Cancer Center; and the Department of Biomedical Engineering and the Institute of NanoBioTechnology at The Johns Hopkins University. He is a clinical expert in inflammatory bowel disease (IBD) and serves as the director of the Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center at Johns Hopkins. Dr. Selaru earned his medical degree at Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. He completed his internal medicine residency at University of Maryland Medical Center in Baltimore and completed his fellowship training in gastroenterology and hepatology at the Johns Hopkins University School of Medicine. Dr. Selaru’s research focuses on the intersection of clinical medicine, engineering and biology. His research expertise is in the utilization of bioengineering tools to answer clinically relevant questions and to translate findings for use in the clinical setting. He established and leads the Selaru lab, a National Institutes of Health-funded laboratory at Johns Hopkins that focuses on inflammation, fibrosis and cancer. The Selaru lab specializes in drug and device development for inflammatory and malignant conditions, as well as tissue regeneration solutions. Some specific projects include drug development for fibrosis in the gastrointestinal tract, microrobot development for oral drug delivery, tissue engineering for fistulas and other tissue defects in IBD, and novel drug targeting approaches for inflammation and cancer. Dr. Selaru’s overarching goal is to deliver medical products and technologies to patients with IBD and cancer.

Our expert clinicians at The Johns Hopkins Division of Gastroenterology and Hepatology at Johns Hopkins Hospital offer a full range of gastroenterology and hepatology services including endoscopy and motility studies.